Renalytix Plc (LON:RENX – Get Rating)’s stock price traded up 5% on Friday . The stock traded as high as GBX 105 ($1.28) and last traded at GBX 105 ($1.28). 9,191 shares were traded during trading, a decline of 77% from the average session volume of 40,094 shares. The stock had previously closed at GBX 100 ($1.22).
Renalytix Price Performance
The company has a fifty day moving average price of GBX 80.02 and a two-hundred day moving average price of GBX 80.97. The company has a current ratio of 2.58, a quick ratio of 2.42 and a debt-to-equity ratio of 59.10. The company has a market cap of £78.64 million and a price-to-earnings ratio of -2.13.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score.
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.